The work of the Innovation Center has benefited from continuity across administrations; the path to further expanding ...

New Year’s is receding fast in the rearview mirror. And for many of us, our sincere resolutions about losing weight and ...

Just two weeks into 2025, January is proving why it’s earned a reputation as the worst month for layoffs. | Just two weeks ...

The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

An estimated 50m people live with dementia globally, more than two-thirds of them in low- and middle-income countries. In 2024, the first drugs that can change the course of Alzheimer’s disease ...

Recent headlines suggest that up to 42% of people ages 55 and older face an eventual dementia diagnosis. But some experts have a follow-up message: Risk isn't the same as destiny, and there are ways ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...

While the condition remains incurable, there are a ... Nov. 19, 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ... Earlier Diabetes ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being developed in Hamilton after a McMaster University researcher discovered a new ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...